Use of omalizumab in the treatment of food allergy and anaphylaxis.
about
Cow's Milk Protein Allergy.Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoringOmalizumab in children.Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental MediciStructural basis of omalizumab therapy and omalizumab-mediated IgE exchange.An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis.Basophils and allergic inflammationPhase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.Successful prevention of recurrent anaphylactic events with anti-immunoglobulin E therapy.Prevention of anaphylaxis in healthcare settings.Immunotherapy in allergy and cellular tests: state of art.Interaction between allergic asthma and atherosclerosis.From IgE to Omalizumab.Pearls and Pitfalls in Diagnosing IgE-Mediated Food Allergy.Comparable actions of omalizumab on mast cells and basophils.Recombinant Antibody Fragments for Neurodegenerative Diseases.New pharmaceutical approaches for the treatment of food allergies.A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit α (FcεR1α) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand.
P2860
Q30248217-75B586F6-5D4A-47FB-88C1-1D247DD3743CQ34432067-52817E75-B3CC-4446-BCD6-908A2B2979ACQ34604574-D7A22892-F982-4FB6-954F-3FCFECB073A8Q35777144-5E792F0C-3C58-4B64-BCA2-A78C254ED784Q36919753-C3ED4F4B-0DD3-49DC-8217-0E02C850901FQ37288228-158E2FBD-4F34-4E93-B554-5064D1196F54Q37520281-CB711D8E-266E-4745-9515-990FA80A351FQ37607069-B7A99CA9-764A-4208-8589-6C1A57BC987FQ37733679-09034B82-63A4-4F1C-90A8-9D2D2F76DD11Q38144110-CF0EDC9C-21DE-4B7B-8252-4BABB41FDC0FQ38203380-F352373F-26CE-4CDE-BEE5-57CFDEC18BD7Q38648016-6A13A1D3-9268-4639-B558-3421C78BD90DQ38793428-245A8264-14F7-467A-BCBA-6F179487C8D6Q38796721-294D34A2-A347-4901-B946-EFB08BB96D61Q38824255-EBC0A888-5DA5-427F-81C1-8FE9A63E2FA6Q38970823-33422DD5-05C6-4B6A-B921-477C95DAFDA6Q38978845-B81B7E56-2E31-4221-A409-DEE7425A730BQ40433571-EF752A08-2958-4AC3-B68B-4CD00D131D66
P2860
Use of omalizumab in the treatment of food allergy and anaphylaxis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of omalizumab in the treatment of food allergy and anaphylaxis.
@en
type
label
Use of omalizumab in the treatment of food allergy and anaphylaxis.
@en
prefLabel
Use of omalizumab in the treatment of food allergy and anaphylaxis.
@en
P2860
P1476
Use of omalizumab in the treatment of food allergy and anaphylaxis.
@en
P2093
Jay A Lieberman
Mirna Chehade
P2860
P2888
P356
10.1007/S11882-012-0316-X
P577
2013-02-01T00:00:00Z
P6179
1026742717